Press Releases

Year

Mar 11 2026

GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications

Collaboration expands access to trusted therapies with discounted cash prices for leading brands including Lipitor®, Celebrex®, Viagra®, and Norvasc® SANTA MONICA, Calif. --(BUSINESS WIRE)--Mar. 11, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today

PDF Version

Mar 06 2026

GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®

GoodRx Employer Direct enables self-insured employers to subsidize the $449 Lilly Employer Connect medication price for Zepbound KwikPen to reduce employee out-of-pocket costs Brief Summary: GoodRx to collaborate with Eli Lilly to expand employer-sponsored access to Zepbound® KwikPen®, an

PDF Version

Feb 25 2026

GoodRx Reports Fourth Quarter and Full Year 2025 Results

Fourth Quarter and Full Year 2025 Revenue and Adjusted EBITDA Results In-line with Previous Guidance Pharma Direct Revenue Beats Previous Outlook with Over 40% Year-Over-Year Growth for 2025 SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 25, 2026-- GoodRx Holdings, Inc.

PDF Version

Feb 24 2026

GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”

New program combines employer-subsidized discounted cash prices and custom telemedicine solutions with existing health benefits to close coverage gaps and support access to high-impact medications SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 24, 2026-- GoodRx (Nasdaq: GDRX), the leading platform

PDF Version

Feb 05 2026

GoodRx Powers Pricing for Leading Brand Medications on TrumpRx

Brief Summary: GoodRx is a core integration partner for TrumpRx, powering the pricing for leading brand medications At launch, GoodRx is the integrated pricing source on TrumpRx for Pfizer, including over 30 of Pfizer’s essential brand medications spanning women’s health, arthritis, and more By

PDF Version

Feb 02 2026

GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale

Independent assessment validates GoodRx’s continued leadership in cybersecurity and data protection SANTA MONICA, Calif. --(BUSINESS WIRE)--Feb. 2, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced it has earned its 2026 certification status

PDF Version

Jan 28 2026

GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 28, 2026-- GoodRx Holdings, Inc. (Nasdaq: GDRX) (“GoodRx” or the “Company”), the leading platform for prescription savings in the U.S., today announced it will release its fourth quarter and full year 2025 financial results after U.S.

PDF Version

Jan 08 2026

GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies

Program offers Giant Eagle customers instant access to meaningful savings on brand medications SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 8, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S. , today announced the launch of RxSmartSaver powered by GoodRx at

PDF Version

Jan 05 2026

GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill

Consumers can soon go to GoodRx for Weight Loss to determine eligibility and obtain a prescription for the first and only oral GLP-1 formulation SANTA MONICA, Calif. --(BUSINESS WIRE)--Jan. 5, 2026-- GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S.

PDF Version

Press Releases

site - Investor Tools